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The concept of a  spirally wrapped cell membrane as the mode of origin of the myelin 
sheath has made it difficult to explain  (a) myelin sheath adjustment  to growth of the 
axon in diameter and length,  (b)  the herniation  and implied flexibility of the myelin 
sheath  observed  in  normal  fibers  (1),  (c)  the  ability  of myelinated  axons  in  tissue 
culture to lose and regain  myelin in relatively rapid response  to the application  and 
withdrawal of noxious stimuli (2), and (d) the varied responses of myelin in pathologic 
situations  (3). 
Potential and actual spaces have been demonstrated  between  the outer surfaces of 
the myelin lamellae  (intraperiod  line)  by exposure to hypotonic solutions (4) and by 
penetration  of lanthanum solutions? Cytoplasmic trapping is often observed between 
the  inner surfaces  (5).  Separation  of myelin layers has  been induced  by irradiation 
damage to Schwann cells in vitro  (6).  While recent evidence suggests that preferred 
orientation and positioning of Schwann or glial cytoplasmic microtubles are influential 
in the over-all maintenance of a flexibly stable sheath form (7), the above observations 
are  consistent with  a  picture  of a  stable  myelin sheath  adaptable  to necessary form 
changes by temporary separation,  slippage,  and retightening  of the spirally wrapped 
constituent lamellae  (3). 
Our view of the structural  form of myelin regards  the electron  opaque loci of the 
outer and inner surfaces of the cell membrane not as "leaflets"  but simply as regions 
of charge  distribution  to which  osmium,  dichromate  ions,  permanganate  ions,  etc. 
may be selectively bound. 2 This, in agreement with prevailing ideas about the myelin 
sheath  and  cell  membranes,  supports  the  thesis  that  a  structural  order  prevails,  as 
demonstrated by polarization optics and X-ray diffraction (8). In this general scheme, 
liquid-crystalline  smectic arrays of bimolecular  lipid  layers containing  the phospho- 
lipid  and  cholesterol  molecules  alternate  with  protein  and/or  polysaccharide  com- 
ponents.  The  ability  of the  cell  surface  to  respond  quickly  to change  in  shape  and 
volume,  as well as  the necessity during  myelin formation for the  Schwann  (or glial) 
1  Karnovsky, M. J., and J.-P. Revel.  1967. Personal communication. 
2 We have been able to confirm with  the electron  microscope  that chromate ions  compete with 
osmium for binding sites in the myelin sheath  (this is the basis of the lack of blackening by normal 
nerve  in  the  Marchi  staining  reaction).  Dichromate  also  binds  to  the  outer  surface  of 
the cell membrane in such  a way that the myelin period is larger after  dichromate fixation  than 
after osmium fixation (in our hands,  170 vs. 110 A for methacrylate imbedding) and the intermediate 
dense line  of myelin is represented  by two electron-opaque zones. Dichromate binding within the 
myelin sheath leads to periodic bands of electron opacity that can be reinforced by staining  Araldite 
sections in nranyl or permanganate solutions, but not in aqueous solutions of osmium tetroxide. 
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cell  membrane to increase  by incorporation  of molecular components  (9),  must de- 
pend  on  the  "fluid"  aspects of this  state  and  make it necessary to  consider ways in 
which molecules can be added  to the membrane. 
During  the  past  decade,  Davison,  Dobbing,  and  their  coworkers  have  provided 
evidence for the stability of myelin constituents in the central and peripheral nervous 
systems (10-22).  In general,  their conclusions have been based on the incorporation 
into brain or white matter of parenterally administered, labeled lipids or other myelin 
precursors during myelination and  their retention  until adult life in chicks, rats,  and 
rabbits.  Comparison of the incorporation data in young animals with similar data in 
adult rats led  them to consider the existence of a  "fast"  (quickly turned  over) meta- 
bolic pool in myelin as well as a relatively inert but slowly turned over class of myelin 
components.  They  have  attributed  the  metabolic  inertness  of myelin  to  its  mem- 
branous lamellar components.  Further,  they have recently emphasized  the vulnera- 
bility of the myelinating nervous system to undernutrition  as well as the known resist- 
ance of mature brain components to starvation (23). 
Although  the  composition  of mature  myelin  suggests  an  inert  state,  significant 
molecular movements may take place. Davison and Wajda have conclusively demon- 
strated that cholesterol enters white matter (24).  Salpeter and Singer have published 
evidence  that,  while  isotopically labeled  leucine  enters  the  axon from the  neuronal 
end  (25),  radioactive  histidine  may  "move"  through  myelin  anywhere  along  the 
length of the nerve fiber (26).  On the basis of these observations, one is led to inquire 
where  and  in  what  form new  molecules enter  myelin.  Further,  if myelin in  vivo is 
relatively metabolically inert as concerns its complement of chemical constituents,  is 
it subject to a  type cf internal nzolecular rearrangement or even reuse from sheath to 
sheath? 
We  have  observed  that  lamellar  bodies,  normally present  in  mouse  optic  nerves 
during active myelination (12-21  days of age) are found only in very small numbers 
in the mature animal. Since the accumulation of myelin lipids in mouse brain proceeds 
more quickly than myelin sheaths can be detected  by Luxol fast blue staining or by 
electron microscope survey (27), we have come to regard the lamellar body as a  tran- 
sient storage depot of myelin lipid  constituents.  This suggests  that  the  lipid  compo- 
nents  of  myelin  are  accumulated  in  one  morphologically  recognizable  form  (the 
lamellar body) before being incorporated into the myelin sheath. A probable example 
of failure of this system is the wobbler-lethal mouse in  which the lamellar body fails 
to disappear and is caught within the myelin lamellae where it undergoes degenera- 
tion.  In this  site it becomes Marchi  positive,  and  is  associated with  single fiber de- 
generation,  presumably by axonal tamponade. 
The advent of stable, isotopically labeled myelin constituents and the development 
of high-resolution,  light  and  electron  microscopic,  radioautographic  methods  have 
led us to undertake a  detailed assessment of the location and route of entry of choles- 
terol in  myelin.  Incorporation of labeled cholesterol is now being studied  at various 
stages during  myelin formation, as well as at various time intervals after injection in 
normal mice, in the wobbler-lethal mouse, and during degeneration and regeneration 
of myelin. 
We report here  preliminary observations  based  on  data  obtained  in  Swiss  albino All figures are radioautographs of sections  of sciatic nerves of Swiss albino mice injected 
intraperitoneally  with cholesterol-  1,2 -3H. 
First number, age of injection; second number, age at sacrifice;  third  number, num- 
ber of days emulsion exposed to section. Statistical validation of suggested  interpretations 
is in progress. 
FICURE I.  8 d/8 d  +  4 hr/27 dx. Attention is drawn to heavy labeling of perineurium 
4 hr after injection. Diffuse activity is apparent in the nerve with some labeling of myelin 
sheaths. 
FIGURE 2.  5 d/9 d/10 dx. Apparent labeling of myelin sheaths. 
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FIGURE 3.  5 d/9 d/17 dx. Minimal activity over perineurium after 4 days. 
FlouRz  4.  8 d/12 d/17 dx.  Myelin labeling. 
mice.  140-160  ~c cholesterol-l,2-3H  (New England  Nuclear  Corp.,  Boston,  Mass.) 
were injected intraperitoneally using 6 % dimethylformamide in 5 % dextrose (specific 
activity,  1.89  mc/ml)  as  the  vehicle,  at  ages in  which  sciatic  nerve  myelination  is 
known to be active (5-8 days after birth) and to be relatively less active (12 days after I2S  CELL  MEMBRANE  BIOPHYSICS 
FICURES 5  and  6.  8  d/>35  d/7  dx  and  5  d/>35  d/17  dx,  respectively.  Apparent 
persistence of a small fraction of initial  activity in myelin sheaths of mature  animal. 
birth).  The animals have been sacrificed at  1 or 4  hr and  1, 3, 4, 7, or >35 days after 
injection  of labeled  cholesterol.  Tissues  were  fixed  by immersion  in  5 %  cacodylate- 
buffered  glutaraldehyde,  postfixed  in  chrome-osmium  solution  (Dalton's),  rapidly 
dehydrated  in  graded  acetones,  and  infiltrated  and  imbedded  in  an  Epon-Araldite B.  G.  UZMAN AND  E.  T.  HEnLEY-WHYaX  Myelin."  Dynamic or Stable?  I3s 
mixture  (28).  Sections  (±1  •)  were mounted on glass slides and coated with Kodak 
NTB-2 emulsion. After suitable exposure times the slides were developed with D-170 
(29)  or Dektol (1 : 1),  fixed in Edwal or Kodak Acid Fixer, washed,  and dried.  Some 
sections were stained with 0.2 %  toluidine  blue and mounted in  Epon-Araldite  (30). 
Other sections were mounted in Zeiss phase-mounting medium, n  =  1.535. 
The discussion of our results is predicated on the assumption that radioactivity, as 
indicated  in  technically  suitable  radioautographs,  reflects  the  location  of  labeled 
cholesterol.  Evidence that the 3H in the cholesterol- 1,2-3H molecule is stable is sum- 
marized  in  the  appendix.  For  clarity  and  convenience we  have  employed for each 
specimen  a  notation  indicating  age  at  injection/age  at sacrifice/number  of days of 
exposure of NTB-2 emulsion to the tissue section, e.g., 8 d/9 d/20 dx. 
Fig.  1 (8 d/8 d  +  4 hr/27 dx) indicates that  shortly after intraperitoneal  injection, 
labeled  cholesterol  accumulates  markedly in  the  perineurium  and  to some extent is 
detectable in  myelin sheaths.  Labeling of myelin can  also be seen in  Figs.  2  (5  d/9 
d/10 dx), 3  (5 d/9 d/17 dx),  and 4  (8 d/12 d/17 dx).  Fig. 3 is from a  nerve removed 
4 days after injection of label; there is very little persistent perineural label (compare 
with Fig.  1 in which the nerve was removed 4  hr after injection of label).  Such peri- 
neural labeling must, therefore,  be a  transient phenomenon. 
On the other hand, label persists in mouse sciatic myelin until maturity, as demon- 
strated in Fig.  5  (8 d/>35  d/7 dx).  The fact that the grains are few and far between 
in the mature animal could be accounted for by further growth of the myelin sheath 
after injection of the labeled cholesterol,  by the relatively short exposure of emulsion 
to section,  or by loss of labeled cholesterol with time. We shall have to make appro- 
priate statistical analyses of more amply recorded data to check on the first possibility 
and use longer exposure times to rule out the second,  before attributing lack of label 
to loss of cholesterol.  In this regard, a nerve from an animal injected with cholesterol- 
1,2-3H at 5  days of age was removed after 35  days  of  age.  Here  (Fig.  6,  5  d/>35 
d/15 dx) a  l 5 day exposure of emulsion to section reveals little evidence of cholesterol 
retention until maturity. 
A  further point of interest in  the  problem of cell membrane growth as  related  to 
myelin formation concerns sites of entry of new components into myelin. We hope to 
be able to distinguish  entry through  the peripheral  Schwann  cytoplasmic layer from 
entry through the axon by examination of transverse sections. Our preliminary results 
as shown in Fig.  7  (8 d/9 d/7 dx) and Fig.  8  (8 d/>35  d/7 dx) show practically no 
label over axons. An intermediate sample, Fig.  9  (8 d/12 d/17 dx) suggests a  stage in 
which label reaches the axon, but, as shown in Fig.  7, myelin labeling does not appear 
to be solely (if at all) dependent on entry via an axonal pathway. 
Finally, we have examined a  nerve from an animal into which labeled cholesterol 
had  been injected  at the age of 12 days.  Peripheral myelination in the mouse, while 
incomplete  at  this  age,  is  known  to  be  well  advanced.  Fig.  10  (12  d/12 
d  -t-  4  hr/20  dx)  shows  very little  incorporation  of  cholesterol  in  perineurium  or 
myelin compared to the example of Fig.  1 (8 d/8 d  -¢- 4 hr/27 dx). 
While  our  data  is  based  on  a  limited  number  of observations,  radioautographic 
evidence of the incorporation of lipids and lipid precursors into white matter of brain 
has been reported (31). In this study the localization of the tagged molecules in myelin 
sheaths was not specifically established. Work on the in vitro incorporation of choline- ~4 s  CELL  MEMBRANE  BIOPHYSICS 
FIGURES 7 and 8.  8 d/9 d/7 dx and 8 d/>35 d/7 dx,  respectively. Compare lack of 
axonal label in these two instances (1  and 27 days after injection of label) with Fig. 9. 
methyl-all chloride into myelin has not been reported in sufficient detail for precise 
interpretation  (32). Further accumulation of evidence from experiments such as those 
which have been described and reviewed here should lead to an understanding of the 
dynamic aspects of myelin metabolism while allowing for the known stable structure. FIaURE 9.  8  d/12  d/17 dx. This cross-section from a  nerve 4  days after injection indi- 
cates label can occur over axons although labeling of mid-axonal regions is not a promi- 
nent feature  (Fig.  7)  at earlier times after  injection. 
FIOURE 10.  12 d/12 d  +  4 hr/20 dx. Compare with Fig.  1. More mature nerve (heavil~ 
myelinated)  of 12  days  shows much  less perineural  labeling  (lower right-hand  corner 
and  much less diffusely distributed  label over nerve fibers than  the 8  day sciatic nerve 
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Appendix 
Several workers have attempted to establish the biological stability of tritium-labeled  steroids 
including cholesterol.  The methcds of doing this have involved the use of mixtures containing 
tritium and carbon 14-labeled molecules with the determination of the ratio of ~H/14C in the 
original mixture and in the metabolites or the same substance reisolated from men or animals. 
Wood  et  al.  (33)  fed  a  mixture of cholesterol-1,2-3H and cholesterol-4-'4C  to  a  human 
adult and found a constant 3H/~4C ratio in the plasma and duodenal aspirate over a period 
of 31 days. Chevallier (34) found constant 3H/14C ratios in the excreta of rats 13-18 days after 
subcutaneous injection of a  mixture of labeled cholesterol-3H  and cholesterol-4-14C. Werbin 
et al.  (35)  found constant 3H/14C ratios in plasma cholesterol and urinary steroids for  10 days 
after  intravenous  administration  of  a  mixture  of  generally  labeled  cholesterolAH  and 
cholesterol-4-14C to an adult male. They ccncluded that tritium-labeled cholesterol was suffi- 
ciently stable  for  tracer  studies. 
Other studies can be cited as indirect evidence of the stability of tritium attached  to the 
first ring of the sterols.  Gold and Crigler (36)  showed  that after administration of a mixture 
of cortisol-I ,2-3H  and cortisol-4-14C to an adult man, the ratios of ~H/I4C in the metabolites 
remained constant for 94 hr.  Osinski (37)  incubated a doubly labeled molecule cortisol-1,2- 
~H-4-14C with rat liver slices and obtained the same 3H/~4C ratio in the metabolites as  were 
present in the original substance. 
The above cited work has depended on the biological stability of the fourth carbon atom. 
Davison and Wajda (24)  demonstrated that cholesterol recovered from the brain of 1 yr old 
rabbits who had been injected with cholesterol-4-14C at the age of 17 days was still labeled at 
the  fourth  carbon  position. 
Note Added in Proof--Since  submission of this  manuscript definitive evidence of the 
long term stability of  cholesterol-l, 2-~I-I in mice has  been obtained; the  intepreta- 
tions here have  been confirmed and  extended  by further observations and detailed 
statistical analysis; all work is in preparation for publication by E. TI  Hedley-Whyte, 
B. G. Uzman, and F. A. Rawlins. 
These studies were supported by research grant NB-00190 from the National Institute of Neurological 
Diseases and  Blindness, National Institutes of Health,  grant 501A from  the  National Multiple 
Sclerosis Society, a grant from the Legacy  of Loula D.  Lasker,  and a grant from  the Albert and 
Mary Lasker Foundation in New York City. 
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